Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
7 Fun Plans to Make Film Evenings Seriously Energizing (You'll Cherish #5!)- Mystery foot suggests a second early human relative lived alongside Lucy
- Saturn shines with the waxing moon at sunset on Nov. 29
- More parents refusing this shot that prevents serious bleeding at birth
- California warns of death cap mushrooms outbreak resulting in 3 deaths
- Old photos misrepresented as aftermath of political party supporters' brawl in Bangladesh
- Thermo Fisher wins contracts as pharma shifts production to US, CEO says
- I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- Experts who once backed 'shaken baby' science now fight to free imprisoned caregivers
